Blood group distribution and life-expectancy: A single-centre experience

Blood Transfusion

Volumn 13, Issue 2, 2015, Pages 313-317

  Mengoli, Carlo ^a   Bonfanti, Carlo ^b   Rossi, Chiara ^b   Franchini, Massimo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CARDIOVASCULAR MORTALITY; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; INFANT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; ELECTRONIC HEALTH RECORD; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY;

BLOOD GROUP ANTIGEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GROUP ANTIGENS; CHILD; CHILD, PRESCHOOL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MIDDLE AGED;

EID: 84927564462     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0159-14     Document Type: Article

References (18)

1. Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48-59.
2. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998;38:975-88.
3. Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007;5:14.
4. Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012;49:137-49.
5. Wu O, Bayoumi N, Vickers MA, Clark P. ABO (H) blood groups and vascular disease: a systematic review and metaanalysis. J Thromb Haemost 2008;6:62-9.
6. Dentali F, Sironi AP, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012;38:535-48.
7. Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus 2013;11:164-5.
8. Dentali F, Sironi AP, Ageno W, et al. ABO blood group and vascular disease: an update. Semin Thromb Hemost 2014;40:49-59.
9. Franchini M, Crestani S, Frattini F, et al. ABO blood group and von Willebrand factor: biological implications. Clin Chem Lab Med 2014;52:1273-6.
10. Shimizu K, Hirose N, Ebihara Y, et al. Blood type B might imply longevity. Exp Gerontol 2004;39:1563-5.
11. Brecher ME, Hay SN. ABO blood type and longevity. Am J Clin Pathol 2011;135:86-98.
12. Vasto S, Caruso C, Castiglia L, et al. Blood group does not appear to affect longevity: a pilot study in centenarians from western Sicily. Biogerontol 2011;12:467-71
13. O'Donnell JS, Lasffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001;11:343-51.
14. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-5.
15. Koster T, Blann AD, Briët E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.
16. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor and coronary heart disease: prospective study and metaanalysis. Eur Heart J 2002;23:1764-70.
17. Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013;11:491-9.
18. Kak VK, Gordon DS. ABO blood groups and Parkinson's disease. Ulster Med J 1970;39:132-4.